171 related articles for article (PubMed ID: 36525320)
61. Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.
Tekinalp A; Kars TU; Dikici HZ; Yılmaz PD; Demircioğlu S; Çeneli Ö
J Oncol Pharm Pract; 2022 Mar; 28(2):449-452. PubMed ID: 34549658
[TBL] [Abstract][Full Text] [Related]
62. Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
Liu JK; Kan P; Schmidt MH
Neurosurg Focus; 2003 Aug; 15(2):E10. PubMed ID: 15350041
[TBL] [Abstract][Full Text] [Related]
63. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
64. CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement.
Asano H; Imai Y; Ota S; Yamamoto G; Takahashi T; Fukayama M; Kurokawa M
Int J Hematol; 2010 Oct; 92(3):550-2. PubMed ID: 20838960
[TBL] [Abstract][Full Text] [Related]
65. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
66. Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
Suzuki T; Maruyama D; Miyagi-Maeshima A; Nomoto J; Tajima K; Ito Y; Hatta S; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Taniguchi H; Izutsu K; Kobayashi Y; Tobinai K
Cancer Med; 2021 Aug; 10(15):5101-5109. PubMed ID: 34105893
[TBL] [Abstract][Full Text] [Related]
67. Signet ring cell-like diffuse large B-cell lymphoma involving the breast: a case report.
Zhang L; Min Q; Bi J; Yu X; Liang Y; Shao M
BMC Womens Health; 2023 Mar; 23(1):119. PubMed ID: 36949419
[TBL] [Abstract][Full Text] [Related]
68. Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report.
Li S; Sun Y; Shao C; Xu K; Huang H
Thorac Cancer; 2019 Oct; 10(10):2035-2039. PubMed ID: 31452347
[TBL] [Abstract][Full Text] [Related]
69. Primary diffuse large B-cell lymphoma of the mandible. A case report.
Pié-Sánchez J; Petit J; Figueiredo R; Gay-Escoda C
Minerva Stomatol; 2011; 60(1-2):87-92. PubMed ID: 21252853
[TBL] [Abstract][Full Text] [Related]
70. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
71. Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.
Hojo N; Nagasaki M; Mihara Y
World J Clin Cases; 2022 Jun; 10(17):5708-5716. PubMed ID: 35979119
[TBL] [Abstract][Full Text] [Related]
72. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
[TBL] [Abstract][Full Text] [Related]
73. Diffuse Large B-cell Lymphoma (Leg Type) Originating in the Skin of the Right Cheek Region: A Case Report and Literature Review.
Wei Y; Liu L; Bu L; Zhan X; Xu H; Wang S
Ear Nose Throat J; 2023 Sep; ():1455613231202192. PubMed ID: 37776289
[TBL] [Abstract][Full Text] [Related]
74. Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2023 Aug; 98(8):1326-1332. PubMed ID: 37434388
[TBL] [Abstract][Full Text] [Related]
75. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
76. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
[TBL] [Abstract][Full Text] [Related]
77. Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapy.
Kim HY; Oh SY; Lee S; Lee DM; Kim SH; Kwon HC; Hong SH; Yoon JH; Kim HJ
Acta Haematol; 2008; 120(3):150-2. PubMed ID: 19039206
[TBL] [Abstract][Full Text] [Related]
78. (18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
Samarghandi A; Gru AA; Natwa M; Barker DW
Clin Nucl Med; 2015 Jun; 40(6):506-8. PubMed ID: 25742229
[TBL] [Abstract][Full Text] [Related]
79. Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
Strüßmann T; Fritsch K; Baumgarten A; Fietz T; Engelhardt M; Mertelsmann R; Ihorst G; Duyster J; Finke J; Marks R
Br J Haematol; 2017 Sep; 178(6):927-935. PubMed ID: 28643323
[TBL] [Abstract][Full Text] [Related]
80. Lymphoproliferative disorders after immunosuppressive therapy for aplastic anemia: a case report and literature review.
Suzuki Y; Niitsu N; Hayama M; Katayama T; Ishii R; Osaka M; Miyazaki K; Danbara M; Horie R; Yoshida T; Nakamura N; Higashihara M
Acta Haematol; 2009; 121(1):21-6. PubMed ID: 19295190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
